AI Tool Comparison
Paige vs AKASA
An objective side-by-side comparison based on global rankings, AI scores, and monthly user data.
Higher ranked
Paige
HealthcareAI for pathology and cancer diagnosis.
AI Score86.6 / 100
#64
Global rank
–
Monthly users
VS
AKASA
HealthcareAI platform for healthcare revenue cycle operations.
AI Score63.4 / 100
#544
Global rank
–
Monthly users
Side-by-Side Comparison
| Paige | AKASA | |
|---|---|---|
| Category | Healthcare | Healthcare |
| Global Rank | #64 | #544 |
| AI Score | 86.6/100 | 63.4/100 |
| Monthly Users | – | – |
| Pricing | Contact Sales | Contact Sales |
| Website | paige.ai | akasa.com |
Pros & Cons
Paige
- First FDA De Novo authorized AI in digital pathology
- EU IVDR certification for Paige Prostate
- Backed by Tempus and a very large slide dataset
- No public pricing
- Reimbursement for digital pathology AI has lagged
- Product roadmap now depends on Tempus
AKASA
- Works within existing systems
- Focused on a clear problem area
- Well funded, per aggregators
- Little public customer outcome data
- Series C details are from aggregators only
- No public pricing